Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party ; volume:59 ; number:2 ; day:2 ; month:12 ; year:2023 ; pages:247-254 ; date:2.2024
Bone marrow transplantation ; 59, Heft 2 (2.12.2023), 247-254, 2.2024
- Creator
-
Duque Afonso, Jesús
Finke, Jürgen
Ngoya, Maud
Galimard, Jacques-Emmanuel
Craddock, Charles
Raj, Kavita
Bloor, Adrian
Nicholson, Emma
Eder, Matthias
Kim, Orchard
Valerius, Thomas
Snowden, John A.
Tholouli, Eleni
Crawley, Charles
Collin, Matthew
Wilson, Keith M. O.
Gadisseur, Alain
Protheroe, Rachel
Wagner-Drouet, Eva Maria
Savani, Bipin N.
Spyridonidis, Alexandros
Ciceri, Fabio
Nagler, Arnon
Mohty, Mohamad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-023-02150-w
- URN
-
urn:nbn:de:101:1-2404160816018.742718209703
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duque Afonso, Jesús
- Finke, Jürgen
- Ngoya, Maud
- Galimard, Jacques-Emmanuel
- Craddock, Charles
- Raj, Kavita
- Bloor, Adrian
- Nicholson, Emma
- Eder, Matthias
- Kim, Orchard
- Valerius, Thomas
- Snowden, John A.
- Tholouli, Eleni
- Crawley, Charles
- Collin, Matthew
- Wilson, Keith M. O.
- Gadisseur, Alain
- Protheroe, Rachel
- Wagner-Drouet, Eva Maria
- Savani, Bipin N.
- Spyridonidis, Alexandros
- Ciceri, Fabio
- Nagler, Arnon
- Mohty, Mohamad
- SpringerLink (Online service)
Other Objects (12)
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party
Untersuchung zur Pharmakokinetik von Melphalan
Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database
Pharmakokinetik von Melphalan, Busulfan und Chlorambucil
Pharmakogenetik des Zytostatikums Melphalan : Charakterisierung des Membrantransportes
Intravitreal melphalan for persistent retinoblastoma vitreous seeds
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
Looking Ahead: Clinical Hematology International Turns One
Clinical Hematology International: Why a New Journal in Hematology?
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party
Untersuchung zur Pharmakokinetik von Melphalan
Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database
Pharmakokinetik von Melphalan, Busulfan und Chlorambucil
Pharmakogenetik des Zytostatikums Melphalan : Charakterisierung des Membrantransportes
Intravitreal melphalan for persistent retinoblastoma vitreous seeds
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
Looking Ahead: Clinical Hematology International Turns One
Clinical Hematology International: Why a New Journal in Hematology?
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party
Untersuchung zur Pharmakokinetik von Melphalan
Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database
Pharmakokinetik von Melphalan, Busulfan und Chlorambucil
Pharmakogenetik des Zytostatikums Melphalan : Charakterisierung des Membrantransportes
Intravitreal melphalan for persistent retinoblastoma vitreous seeds
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
Looking Ahead: Clinical Hematology International Turns One